About this trial
PENG block will be done on patients with hip fracture either receiving antithrombotic therapy or not under ultrasound guidance
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 65 years or older
diagnosis of hip fracture
scheduled for surgical intervention within 48 hours
Informed consent obtained.
Disqualifiers
Allergy to local anesthetics,
Contraindications to the PENG block
inability to provide informed consent.
Trial design
Parallel
Treatments tested in this trial
PENG block
Procedure/SurgeryUS guided PENG block in hip fracture without anti thrombotic therapy
Treatment groups
Trial outcomes
Primary outcomes
Incidence of Hematoma Formation
The occurrence and severity of hematomas at the PENG block site. Measurement: Regular clinical examinations and imaging studies to assess for hematoma formation.
Bloody Tab on the Needle:
Presence of blood on the needle during the performance of the PENG block.
Rest and mobilization pain by numerical rating scale
post intervention to be assessed 0-10
Secondary outcomes
Incidence of Nerve Injury
Any signs of sensory or motor deficits, paresthesia, or neuropathic pain related to nerve injury or compression due to hematoma formation.
Postoperative quadriceps strength
Quadriceps strength is assessed using the knee extension Test and Oxford muscle strength grading with grouped scores of intact (5/5), reduced (1-4/5) and absent (0/5).
The quality of Postoperative functional recovery and the variations and differences between groups will be assessed using the validated arabic version of the quality-of-recovery 15-items score (QoR-15)
15 values score ranges from 0-150 ,excellent \>135, good \> 122 and \< 135, moderate \>90 and \< 121, poor \< 90
- Perioperative opiate use
will be calculated over 48 hours in milligrams
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: